Indicators of breast cancer severity and appropriateness of surgery based on hospital administrative data in the Lazio Region, Italy

Schifano, Patrizia; Papini, Paolo; Agabiti, Nera; Scarinci, Marina; Borgia, Piero; Perucci, Carlo A.
January 2006
BMC Public Health;2006, Vol. 6 Issue 1, p25
Academic Journal
Background: Administrative data can serve as an easily available source for epidemiological and evaluation studies. The aim of this study is to evaluate the use of hospital administrative data to determine breast cancer severity and the appropriateness of surgical treatment. Methods: the study population consisted of 398 patients randomly selected from a cohort of women hospitalized for first-time breast cancer surgery in the Lazio Region, Italy. Tumor severity was defined in three different ways: 1) tumor size; 2) clinical stage (TNM); 3) severity indicator based on HIS data (SI). Sensitivity, specificity, and positive predictive value (PPV) of the severity indicator in evaluating appropriateness of surgery were calculated. The accuracy of HIS data was measured using Kappa statistic. Results: Most of 387 cases were classified as T1 and T2 (tumor size), more than 70% were in stage I or II and the SI classified 60% of cases in medium-low category. Variation from guidelines indications identified under and over treatments. The accuracy of the SI to predict under-treatment was relatively good (58% of all procedures classified as under-treatment using pT where also classified as such using SI), and even greater predicting over-treatment (88.2% of all procedures classified as over treatment using pT where also classified as such using SI). Agreement between clinical chart and hospital discharge reports was K = 0.35. Conclusion: Our findings suggest that administrative data need to be used with caution when evaluating surgical appropriateness, mainly because of the limited ability of SI to predict tumor size and the questionable quality of HIS data as observed in other studies.


Related Articles

  • Preoperative Measurement of Breast Cancer Overestimates Tumor Size Compared to Pathological Measurement. Jiang, Yi-Zhou; Xia, Chen; Peng, Wen-Ting; Yu, Ke-Da; Zhuang, Zhi-Gang; Shao, Zhi-Ming // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    Background: Tumor size is one of the most important factors in making clinical and pathological assessment of breast cancer. In the present study, we aimed to determine whether the preoperative measurement of tumor size, by imaging modalities, deviate from the postoperative pathological...

  • Effect of margins of excision on recurrence after local excision of ductal carcinoma in situ of the breast. Douglas-Jones, A.G.; Logan, J.; Morgan, J.M.; Johnson, R.; Williams, R. // Journal of Clinical Pathology;Aug2002, Vol. 55 Issue 8, p581 

    Aims: To determine important factors influencing recurrence after local excision of duct carcinoma in situ (DCIS) of the breast. Materials and methods: The extent (size) in millimetres, classification (by cytonuclear grade (NHSBSP system), by extent of necrosis, and by the Van Nuys system), and...

  • Evaluation of alkaline phosphatase in pre and post operative breast cancer patients. Prabasheela, B.; Baskaran, S.; Arivazhagan, R. // International Journal of Biological & Medical Research;May2012, Vol. 3 Issue 3, p1536 

    Background: Breast cancer is the commonest malignancy of women in India. Changes in serum level of some biochemical parameters before and after surgery could assess the effectiveness of surgical intervention in breast cancer patients. Objective: To assay the activity of serum Alkaline...

  • Diaforodiagnostic dilemma of a breast tumor in a patient with known history of chest sarcoidosis: a diagnostic approach. Stavrogianni, Thomai; Psoma, Elisavet; Nikolaidou, Olga; Xinou, Ekaterini; Xirou, Persefoni; Koumpanaki, Melanie; Karoglou, Eleni; Panagiotopoulou, Dimitra // Central European Journal of Medicine;Oct2011, Vol. 6 Issue 5, p537 

    Breast sarcoidosis is extremely rare, substantially less frequent than other extrapulmonary manifestations of sarcoidosis. It can mimic a benign or malignant tumor of the breast. We describe the case of a patient with a history of pulmonary sarcoidosis referred to our hospital for a screening...

  • Evaluation of Onco type DX Recurrence Score as a prognostic factor in Japanese women with estrogen receptor-positive, node-negative primary Stage I or IIA breast cancer. Yorozuya, Kyoko; Takeuchi, Toru; Yoshida, Miwa; Mouri, Yukako; Kousaka, Junko; Fujii, Kimihito; Nakano, Shogo; Fukutomi, Takashi; Hara, Kazuo; Ichihara, Shu; Lin, Yingsong; Kikuchi, Shogo // Journal of Cancer Research & Clinical Oncology;Jun2010, Vol. 136 Issue 6, p939 

    We sought to evaluate the use of the Onco type DX Breast Cancer Assay for identifying candidates for adjuvant therapy in patients with estrogen receptor (ER)-positive, node-negative primary Stage I or IIA breast cancer. A retrospective case–control study was conducted on 40 patients who...

  • Sector resection with or without postoperative radiotherapy for stage I breast cancer: Five-year... Liljegren, G.; Holmberg, L. // JNCI: Journal of the National Cancer Institute;5/4/94, Vol. 86 Issue 9, p717 

    Determines if treatment of stage I breast cancer by standardized surgical technique with confirmation of complete excision can reduce the local recurrence rate to an acceptable level without routine adjuvant radiotherapy.

  • Treatment variation in patients diagnosed with early stage breast cancer in Alberta from 2002 to 2010: a population-based study. Fisher, Stacey; He Gao; Yasui, Yutaka; Dabbs, Kelly; Winget, Marcy // BMC Health Services Research;2015, Vol. 15 Issue 1, p527 

    Background Breast-conserving surgery (BCS) followed by radiotherapy is generally the preferred treatment for women diagnosed with early stage breast cancer. This study aimed to investigate the proportion of patients who receive BCS versus mastectomy and post-BCS radiotherapy, and explore factors...

  • Comparative survival analysis of breast cancer microarray studies identifies important prognostic genetic pathways. Miecznikowski, Jeffrey C.; Wang, Dan; Liu, Song; Sucheston, Lara; Gold, David // BMC Cancer;2010, Vol. 10, p573 

    Background: An estimated 12% of females in the United States will develop breast cancer in their lifetime. Although, there are advances in treatment options including surgery and chemotherapy, breast cancer is still the second most lethal cancer in women. Thus, there is a clear need for better...

  • Waiting time for breast cancer surgery in Quebec. May, Nancy E.; Scott, Susan C.; Shen, Ninggyan; Hanley, James; Goldberg, Mark S.; MacDonald, Neil // CMAJ: Canadian Medical Association Journal;4/17/2001, Vol. 164 Issue 8, p1133 

    Reports on a study to assess the time interval to surgery from diagnosis among Quebec women with breast cancer and to examine the influence on waiting time of age, pattern of care and cancer stage. Methods; Results; Interpretation.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics